首页> 外文OA文献 >Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

【2h】

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

机译：低绝对外周血CD4 + T细胞计数预测R-Chop治疗的弥漫性大B细胞淋巴瘤的患者预后差

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Kusano; M. Yokoyama; Y. Terui; K. Hatake;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma [J] . Y Kusano, M Yokoyama, Y Terui, Blood cancer journal. . 2017,第4期

机译：低的绝对外周血CD4 + T细胞计数预示着R-CHOP治疗的弥漫性大B细胞淋巴瘤患者的预后不良
2. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count [J] . Yan-Li Li, Zhi-Hu Shi, Xian Wang, BMC Cancer . 2019,第1期

机译：肿瘤相关的巨噬细胞预测弥漫性大B细胞淋巴瘤的预后和与外周绝对单核细胞计数的相关性
3. Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant [J] . Mo Hongnan, Shi Yuankai, Han Xiaohong, Leukemia and lymphoma . 2015,第2期

机译：自体外周血干细胞移植后弥漫性大B细胞淋巴瘤患者中单核细胞绝对计数是预后指标
4. Survival Prediction in Patients with Diffuse Large B-cell Lymphoma Using Logistic and Neural Network Models [C] . Chin-Chuan Chang, Chien-Hua Chen, Jer-Guang Hsieh, IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability . 2021

机译：逻辑和神经网络模型弥漫性大B细胞淋巴瘤患者的存活预测
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma [O] . Y Kusano, M Yokoyama, Y Terui, 2017

机译：低绝对外周血CD4 + T细胞计数预示R-CHOP治疗的弥漫性大B细胞淋巴瘤患者的预后不良
7. CIRCULATING LOW ABSOLUTE CD4+ T CELL COUNTS MAY PREDICT POOR PROGNOSIS IN PATIENTS WITH EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE [O] . W. Xu, Y. Zhang, J. Liang, 2017

机译：循环低绝对CD4 + T细胞计数可能预测外骨NK / T细胞淋巴瘤，鼻型患者的预后差

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅